Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths - Top-Institutions - MDSpire

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • By

  • Davide Leardini

  • Giacomo Gambuti

  • Edoardo Muratore

  • Francesco Baccelli

  • Francesca Gottardi

  • Francesco Venturelli

  • Tamara Belotti

  • Arcangelo Prete

  • Marco Fabbrini

  • Patrizia Brigidi

  • Silvia Turroni

  • Riccardo Masetti

  • December 3, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Hematopoietic Stem Cell Transplantation
    • Infectious Diseases
    • Microbiome Research

  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Infectious Diseases
    • Microbiome Research

  • #4

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #5

    University of California, San Francisco (UCSF) Benioff Children's Hospital
    University of California, San Francisco (UCSF) Benioff Children's Hospital

    San Francisco, CA

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Stem Cell Transplantation
    • Infectious Diseases

Original Source(s)

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • by Davide Leardini, Giacomo Gambuti, Edoardo Muratore, Francesco Baccelli, Francesca Gottardi, Francesco Venturelli, Tamara Belotti, Arcangelo Prete, Marco Fabbrini, Patrizia Brigidi, Silvia Turroni, Riccardo Masetti

  • December 3, 2024

Related Content

The Connection Between Periodontal Microbiota and Liver Disease Development: Insights into the Oral-Gut-Liver Axis

Do Head Hits Shift the Gut Microbiome?

A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition

Diabetes Mellitus Following Kidney Transplantation: Mechanisms, Associated Risk Factors, and Treatment Approaches